Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.5.0.2
Accrued expenses and other current liabilities
 9 Months Ended
Sep. 30, 2016
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

 

Note 7 — Accrued expenses and other current liabilities

 

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

 

September 30,
2016

 

December 31,
2015

 

 

 

 

 

 

 

Accrued purchases and clinical trial expenditure

 

$
8,846 

 

$
6,406 

 

Accrued employee compensation and benefits payable

 
572 

 
368 

 

Other current liabilities

 
536 

 
744 

 

 

 

 

 

 

 

 

 

$
9,954 

 

$
7,518